ePrints

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Lookup NU author(s): Helen MossopORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, Graham J, Kirkbride P, Logue J, Malik Z, Money-Kyrle J, O'Sullivan JM, Panades M, Parker C, Patterson H, Scrase C, Staffurth J, Stockdale A, Tremlett J, Bidmead M, Mayles H, Naismith O, South C, Gao A, Cruickshank C, Hassan S, Pugh J, Griffin C, Hall E

Publication type: Article

Publication status: Published

Journal: Lancet Oncology

Year: 2016

Volume: 17

Issue: 8

Pages: 1047-1060

Print publication date: 30/08/2016

Online publication date: 25/06/2016

Acceptance date: 25/06/2016

ISSN (print): 1470-2045

ISSN (electronic): 1474-5488

Publisher: The Lancet Publishing Group

URL: http://dx.doi.org/10.1016/S1470-2045(16)30102-4

DOI: 10.1016/S1470-2045(16)30102-4

Altmetrics

Share